David Penson

Author PubWeight™ 17.61^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The effectiveness of screening for prostate cancer: a nested case-control study.	Arch Intern Med	2006	2.97
2	The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer.	J Surg Oncol	2014	1.59
3	Quality of life after breast cancer diagnosis and survival.	J Clin Oncol	2010	1.24
4	Pay for performance: rationale and potential implications for urology.	J Urol	2007	1.01
5	Differences in health-related quality of life of prostate cancer patients based on stage of cancer.	Psychooncology	2004	0.97
6	Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?	Urology	2005	0.95
7	Treatment of a population based sample of men diagnosed with testicular cancer in the United States.	Urol Oncol	2008	0.92
8	Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients.	Med Care	2016	0.90
9	The development of a telemedical cancer center within the Veterans Affairs Health Care System: a report of preliminary clinical results.	Telemed J E Health	2002	0.85
10	Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy.	J Gastrointest Surg	2013	0.83
11	Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer.	Urol Oncol	2008	0.81
12	Canadian Consensus Conference: The FDA decision on the use of 5ARIs.	Can Urol Assoc J	2012	0.80
13	Adhering to the standard of care for prostate cancer.	Health Aff (Millwood)	2012	0.80
14	Magnetic resonance imaging for locating nonpalpable undescended testicles: a meta-analysis.	Pediatrics	2013	0.79
15	Choledocholithiasis management in rural America: health disparity or health opportunity?	J Surg Res	2011	0.77
16	Outcomes research in urology.	World J Urol	2010	0.77
17	Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study.	J Urol	2007	0.77